ANELYSE financials
A multi-period view of the public annual-account figures reported for ANELYSE, with comparable measures and links to available source documents.
Company overviewRegistry number
0721819461
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for ANELYSE
2025 versus 2024
- Operating line
- €313,458
- EBITDA
- €311,844
- Total assets
- €858,144
- Equity
- €494,634
+21.2%
+21.5%
+13.7%
+24.8%
EBITDA margin +99.5% · Equity ratio +57.6%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | €313,458 | €311,844 | €858,144 | €494,634 | - |
| 202430 Jun 2024 | €258,608 | €256,615 | €754,607 | €396,202 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.